To Compare Intravenous and Oral Hydration of the Prevention for CIN in Elderly Patients Undergoing Intravenous CECT
NCT ID: NCT03872739
Last Updated: 2019-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1368 participants
INTERVENTIONAL
2016-10-08
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Simplified Rapid Hydration in Preventing CA-AKI Among Patients With Chronic Kidney Disease
NCT02232997
Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease
NCT05283512
The Diagnostic Value of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
NCT06353659
Early Screening and Diagnosis of CKD
NCT02841371
The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
NCT06341062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
distilled water
Oral distilled water at the rate of 3 mL/kg/h rate during undergoing enhanced computed tomography examination before 1-2 and after 4-6 hours
enhanced computed tomography
undergoing enhanced computed tomography
Saline
intravenous saline hydration at the rate of 1 mL/kg/h rate during undergoing enhanced computed tomography examination before and after 12 hours
enhanced computed tomography
undergoing enhanced computed tomography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
enhanced computed tomography
undergoing enhanced computed tomography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* informed consent
* Undergoing Intravenous Contrast-enhanced Computed Tomography
Exclusion Criteria
* Dialysis treatment of patients with end-stage renal failure or heart, kidney transplantation;
* Exposure to radioactive contrast medium within 48 hours prior to or within 72 hours of examination;
* Acute decompensated heart failure;
* Allergic to radioactive contrast agent;
* Be subjected to life - threatening trauma;
* Severe infection;
* Surgery was performed within 2 days of CT examination.
* Combined with multiple myeloma, urinary obstruction, aortic dissection
* Can cause acute kidney injury disease;
* Use of aminoglycosides and other nephrotoxic drugs 2 weeks before.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yu Danqing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yu Danqing
Director,Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danqing Yu, Doctor
Role: PRINCIPAL_INVESTIGATOR
Guangdong Cardiovascular Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guangdong provincial people's hospital
Guanzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
huang jieleng, doctor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201704020124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.